<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE298nnn/GSE298870/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Mus musculus</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298870</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>Pharmacological inhibition of sclerostin protects bone from B-cell acute lymphoblastic leukemia-mediated destruction</name><description>The cellular components of the BM microenvironment are known to play a role in the development of B-cell acute lymphoblastic leukemia (B-ALL). However, molecular differences between heathy osteoblastic cells (OBCs) and OBCs associated with B-ALL remain unclear. This study utilises bulk RNA-seq to evaluate the molecular signatures between the healthy OBCs and B-ALL-associated OBCs.</description><dates><publication>2026/05/05</publication></dates><accession>GSE298870</accession><cross_references><GSM>GSM9025359</GSM><GSM>GSM9025357</GSM><GSM>GSM9025358</GSM><GSM>GSM9025364</GSM><GSM>GSM9025362</GSM><GSM>GSM9025363</GSM><GSM>GSM9025360</GSM><GSM>GSM9025361</GSM><GPL>23479</GPL><GSE>298870</GSE><taxon>Mus musculus</taxon><PMID>[42038749]</PMID></cross_references></HashMap>